skip to Main Content

7th Annual Risk Management and Pharmacovigilance Summit

9 – 11 September 2020 | Vienna

The 7th Annual Risk Management and Pharmacovigilance Summit will be the right place to meet the best pharmacovigilance experts from the top pharma companies worldwide, who will share their know-how and latest case studies. All the pharmaceutical professionals are invited to join this business conference and learn the newest trends in pharmacovigilance. The main topics of this international pharmaceutical meeting are proactive safety, inspection readiness, counterfeiting of pharmaceutical products, digitalisation and social media, safety evaluation, the increasing requirements for QPPVs and many others.

Request Full Programme Register Online

 SUMMIT WILL HOST SPEAKERS FROM THE WORLD’S LEADING COMPANIES

See Sample of Key Note Speakers and Their Case Studies.

Gabrielle
AMSELEM

Deputy EUQPPV - PSMF Manager

Mate
BALAZS

Country Head- Patient Safety

Begum
BENLI PEKER

Associate Director, International Operations & PV Intelligence

Karsten
LOLLIKE

Corporate Vice President and QPPV

G. Scott
CHANDLER

Global Head, Personalised Health Care (PHC) Safety

Tjark
REBLIN

Global Head Drug Safety and Risk Management

EXPERIENCE BASED CASE STUDIES

Patient-Centric Approaches to Proactive Safety and Risk Management

The presentation will highlight some recent advances and novel approaches for evaluating toxicity and disease biology in order to demonstrate how proactive and patient-centric approaches can be applied to pharmacovigilance.

Roche

Counterfeit of Pharmaceutical Products – What Are the Risks and How to Mitigate Them?

The fight against counterfeiting is multidisciplinary and collaboration with health authorities and police is vital.

Novo Nordisk

Impacts of Expansion of QPPV and PSMF Requirements

Requirements for Marketing Authorisation Holders to have local Qualified Persons for Pharmacovigilance (QPPV) and Pharmacovigilance System Master File (PSMF) are spreading outside of the EU.

Alexion

HOT CONFERENCE TOPICS

Will Be Discussed

  • Patient-centric approaches to proactive safety and risk management
  • Counterfeit of pharmaceutical products
  • Inspection readiness – How to get ready for an inspection?
  • Safety evaluation and understanding of the safety profile of a medicine
  • Is PIL the best way to communicate risk to patients?
  • Increasing QPPV requirements – Maintenance and expansion of a Pharmacovigilance System Master File (PSMF)
  • The value of direct patient reporting in pharmacovigilance and the inclusion of patients in the decision-making process & Health Literacy
  • Pharmacovigilance in clinical trials within specific populations
  • Engagement of patients and healthcare professionals as fundamental to pharmacovigilance and risk minimisation activities

WHAT DELEGATES SAID

About Allan Lloyds Events

FOR MORE INFORMATION REQUEST FULL PROGRAMME

See what keynote speakers will be taking part in the exclusive speaking panel.
Explore what Case Studies will be discussed by our senior corporate speakers

At Allan Lloyds we understand the value of learning in groups.
Companies are therefore encouraged to avail of the below discounts:
GROUP DISCOUNT
3 or more
delegates 7%
5 or more delegates 10%
7 or more delegates 15%

Back To Top

RELATED EVENT

2nd Annual Global Medical Affairs Summit